Neil Pravin Shah MD
Hematologic Oncology
Assistant Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
200 Medical 530 420 120 Plz"# 365"Los Angeles, CA 90095
Phone+1 310-825-6301
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Neil Shah, MD is an oncologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is an Assistant Professor at UCSF School of Medicine.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2003- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1996 - 1998
David Geffen School of Medicine at UCLAClass of 1996
Certifications & Licensure
CA State Medical License 1998 - 2026
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.Elias Jabbour, Jane Apperley, Jorge Cortes, Delphine Rea, Michael Deininger
Leukemia. 2024-10-01 - 3 citationsAbsence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib.Ariel Leyte-Vidal, RosaAnna DeFilippis, Ian R Outhwaite, Isabelle Kwan, Ji Young Lee
Leukemia. 2024-09-01 - 14 citationsBCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis, Inga B Leske, Delphine Rea
Blood. 2024-08-08
